Prevalence (n (%)) of disability outcomes across ethnic groups: SABRE study 2008–2011.

<p>Data presented as n (%).*Obtained in clinic attendees only: European men/women, n = 489/135, Indian Asian men/women n = 404/57, African Caribbean men/women n = 106/101. p values represent results from comparison with Europeans using χ2 tests.</p

Baseline characteristics by sex and ethnic group: SABRE study 1988–1991.

<p>Data presented are unadjusted means (SD) and %, with exception of physical activity and alcohol consumption, presented as medians (interquartile range), due to skewed data (categorical variables were used for ethnic group comparisons). *p<0.05 for group differences with Europeans as reference category. †n = 959, includes only those people born outside the UK/Ireland with complete data (for European group, n = 61). Physical activity measured in megajoules expended per week during leisure time, travel time and sports. Sedentary behaviour measured as television viewing hours per week.</p

Associations between baseline risk factors and locomotor dysfunction at follow-up (age- and sex-adjusted) by ethnic group: Logistic regression analysis in the SABRE study.

<p>Data presented as odds ratios (95% confidence intervals). Only includes people with complete questionnaire and locomotor function data (n = 1292). SEP: Socioeconomic position. Age, sedentary behaviour, waist circumference, and body mass index coded as continuous variables. Sex, life-course SEP (reference category: Low childhood and low adult), home tenure (reference category: Do not own home), smoking status (reference category: Never/ex-smoker), physical activity (megajoules per week categorised into quartiles, reference category: Lowest), alcohol intake (reference category: Low), self-rated health (reference category: Very good/good), and baseline coronary heart disease, diabetes, hypertension, arthritis, asthma and disability (reference category: No prevalent condition) coded as categorical variables.</p

Follow-up assessment of disability.

<p>Follow-up assessment of disability.</p

Changes in clinical and biochemical characteristics at 24 months by study group.

<p>Changes in clinical and biochemical characteristics at 24 months by study group.</p

Baseline characteristics of clusters and participants by study group.

<p>Baseline characteristics of clusters and participants by study group.</p

Trial profile.

<p>IDRS, Indian Diabetes Risk Score; OGTT, oral glucose tolerance test.</p

Changes in health-related quality of life variables at 24 months by study group.

<p>Changes in health-related quality of life variables at 24 months by study group.</p